In clear cell renal cell carcinoma, Wu et al. (23) built a new survival model based on five risk-related FRGs (CARS, NCOA4, FANCD2, HMGCR, and SLC7A11), which showed strong association with clinicopathological features of patients. This evidence concerns the gene HMGCR and clear cell renal carcinoma.